Smart –AF Continued Access Protocol

Smart –AF Continued Access Protocol
Smart –AF Continued Access Protocol
204450062012

Number of Participants

147

Eligibility

The participant must have symptomatic paroxysmal atrial fibrillation with documentation within one year and failed one antiarrhythmic drug, which can include class I or III, AV nodal blocking agents, such as beta blockers and calcium channel blockers.

Purpose

This research trial is using an investigational catheter during the ablation procedure. The catheter has a sensor that measures the direct contact force between the heart tissue and the tip of the catheter.

Treatment

All eligible participant in this study will have an ablation procedure for their atrial fibrillation using the investigational catheter. The participant will be followed at one month , three months and then every three month for one year. The participants will be given a monitor for surveillance at home.

Principal Investigator

David J. Wilber

M.D., FAHA, FACC
Cardiology
George M. Eisenberg Professor of Cardiovascular Sciences

Enrollment

708-216-2644

More Clinical Trials

See Also

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy